4
Changes in Ownership
Iambic Therapeutics, Inc. Filed Acc 0002154030-26-000007
Director acquired 4,196,585 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogelstein R Jacob Director | 2026-10-16 | Conversion | +1,995,749 | 1,995,749 | I | ||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion | +1,458,290 | 1,458,290 | I | ||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion | +742,546 | 742,546 | I | ||
| Derivatives | |||||||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion · Series A Convertible Preferred Stock | −1,141,878 | 0 | I | ||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion · Series B Convertible Preferred Stock | −731,187 | 0 | I | ||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion · Series B-3 Convertible Preferred Stock | −122,684 | 0 | I | ||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion · Series B-4 Convertible Preferred Stock | −1,458,290 | 0 | I | ||
| Vogelstein R Jacob Director | 2026-10-16 | Conversion · Convertible Promissory Notes | −742,546 | 0 | I | ||
Loading xslF345X06/form4-10192026_111012.xml…